Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the point-of-care glucose testing market grown in recent years?

The market size for point-of-care glucose testing has seen consistent growth over the years. It is projected to escalate from $4.91 billion in 2024 to $5.15 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 4.9%. Factors contributing to the growth in the past include a rise in diabetes occurrence, heightened awareness of diabetes control, expanding elderly population, improvements in healthcare infrastructure, and the adoption of point-of-care testing.

How is the point-of-care glucose testing market size expected to evolve during the forecast period?

In the coming years, significant expansion is projected for the point-of-care glucose testing market. By 2029, its size is anticipated to reach $6.51 billion, with a compound annual growth rate (CAGR) of 6.0%. The growth during the forecast period is largely due to broader telemedicine services, a heightened focus on personalized diabetes treatment, an increase in diabetes management initiatives, greater investment in glucose testing R&D, and widespread adoption of continuous glucose monitoring. Key trends for the forecast period include the rise of wearable glucose monitoring gadgets, the integration of smartphone connectivity in glucose testing devices, the expansion of point-of-care testing in home healthcare environments, the adoption of artificial intelligence for glucose data interpretation, and the broadening scope of remote patient monitoring specifically for diabetes.

Get your point-of-care glucose testing market report here!

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Which key drivers are propelling the point-of-care glucose testing market’s growth?

The increasing incidence of diabetes is anticipated to spur the expansion of the point-of-care glucose testing market in future. Diabetes is a persistent metabolic disease that raises blood sugar levels, causing extensive damage to the heart, blood vessels, eyes, kidneys, and nerves over a long period. Point-of-care glucose testing, a popular technology for measuring glucose levels in hospitalized patients, promotes rapid treatment plans following changes in glycemia, boosts therapeutic outcomes, and enhances diabetes control. For example, The National Health Service (NHS England), a UK-based state-funded healthcare system, reported in June 2024 that the number of people identified as pre-diabetic by the NHS in England escalated to 3,615,330 in 2023, showing an 18% growth from 3,065,825 in 2022. Moreover, there was an approximately 25% increase in cases among those below 40, rising from 173,166 in 2022 to 216,440 in 2023. Consequently, the escalating incidence of diabetes is fueling the expansion of the point-of-care glucose testing market.

What are the market segments in the point-of-care glucose testing industry?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

Which leading companies are shaping the growth of the point-of-care glucose testing market?

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

What key trends are currently impacting the point-of-care glucose testing market’s development?

The emergence of product innovation is a notable trend in the point-of-care glucose testing market as leading corporations prioritize the creation of revolutionary products to strengthen their market presence. For example, in January 2022, F. Hoffmann-La Roche AG, a renowned healthcare firm based in Switzerland, unveiled Cobas Pulse, a state-of-the-art point-of-care blood glucose monitor designed for healthcare professionals. This device comes with a companion gadget that has the look and feel of a modern touchscreen smartphone, complete with its applications. Cobas Pulse, a handheld device, boasts features including auto glucose test strip reader, camera, and touchscreen. These allow for recording diagnostic data in a robust casing that can be sanitized and made suitable for patients of varying ages, from newborns to those in critical care. Aimed at enhancing doctors’ workflow, it combines the Glucommander dosage software with the glucose reader and offers downloadable decision-support applications from businesses such as Smart4Diagnostics, CardioSignal, and SteadySense.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

Which geographic areas are influencing the growth of the point-of-care glucose testing market?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Spray Drying Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Neurostimulation Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Pharmaceutical Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: